摘要
奥拉替尼(Oclacitinib)是一种新型、高效的非受体络氨酸激酶(JAK)抑制剂,用于控制犬类的过敏性皮肤病引起的瘙痒。综述了近年来奥拉替尼的研究进展,介绍和评述了合成路线及方法、药物应用研究。展望了奥拉替尼药物未来的发展趋势。
As a novel and highly effective janus kinase(JAK)inhibitor,for the control of pruritus caused by atopic and allergic skin disease in dogs.The research progress of oclacitinib in recent years was reviewed,with emphasis on the introduction and review of synthetic routes and methods,and the application of drugs.Finally,the future development trend of oclacitinib drugs was prospected.
作者
武鼎铭
吴梦雅
索永波
孙凤楠
侯林
Wu Dingming;Wu Mengya;Suo Yongbo;Sun Fengnan;Hou Lin(Luoyang Huizhong Veterinary Medicine Comany Limited,National Research Center for Veterinary Medicine,Luoyang9 Henan 471000,China)
出处
《化学世界》
CAS
2021年第5期265-270,共6页
Chemical World
关键词
奥拉替尼
合成
应用
oclacitinib
synthesis
application